Member Directory

Contact: Patricia Reynolds

Contact: Stephen Wilks Director

Accountant for startups

Contact: Dave Morrison

Nyman Libson Paul are an established firm of accountants in London with over 80 years experience. Dave has structured and advised on many EIS and SEIS projects across a range of industries but has, in particular, made a significant impact in the Entertainment Industry sector, in which the firm is a significant player. Dave is a Chartered Accountant, Certified Accountant and Chartered Tax Adviser and is also Chairman of the Institute of Chartered Accountants’ Entertainment and Media Group. Dave has specialised in tax for many years, has been published in Taxation magazine as well as many other publications and has previous ‘big firm’ experience. He also ran his own promotions business for several years, which could explain his empathy for entrepreneurs!

Contact: Sunil Shah

o2h Ventures, a specialist biotech fund manager based in the heart of the thriving biotech community in Cambridge, UK. We invest in early-stage biotech companies involved in novel drug discovery, enabling service tools, and AI/ML technologies. Currently, we have two tax-efficient human health funds open for investment: the Enterprise Investment Scheme and the Seed Enterprise Investment Scheme.

To date, through our funds, we have invested over $10 million in 35+ early-stage biotech companies, empowering impactful research addressing unmet medical needs in areas such as cancer, depression, diseases of the ear and eye, psoriasis, idiopathic pulmonary fibrosis, anti-ageing, and infectious diseases. For more details, please see – www.o2hventures.com

Contact: Justine Duggan

Octopus is synonymous with small company investing and is the UK’s largest specialist manager of tax efficient investments, managing more than £13bn on behalf of both retail and institutional investors. Our experience spans more than 20 years and, in that time, we have invested over £2 billion in early-stage companies.

Each Octopus Ventures EIS portfolio will have around 10-15 companies selected for their ambitious growth targets and potential to become a household name of the future. Investors will have access to the expertise of Octopus Ventures, one of the largest venture capital teams in Europe. Our previous track record for identifying, growing and exiting some of Britain’s brightest companies includes investments in Graze, Secret Escapes, Zoopla and Tails.com, to name but a few. Our pipeline of opportunities spans very early stage (seed) through to Series A and Series B investments.

We have aligned our fees with the interests of our investors. Our annual management charge is only payable if a company is sold for more than the amount invested into it.

Contact: Declan McEvilly

Contact: James Nash Founder / Director

Owl B and B A New Short Term Holiday Rental Platform that Disrupts the Market and Saves Users Money

Like Airbnb, but better with transparent pricing and no hidden fees.

Travellers and hosts can now book and list properties confidently due to a clear fixed fee process.

BE WISE BOOK WITH OWL B AND B - IT'S A HOOT!

Contact: David Mott Founder Partner

We invest in seed and early stage companies from a range of different industries, with a particular focus on technology. Oxford Capital is one of the most experienced tax-efficient investment managers in the UK. Since pioneering the first EIS funds in 1999, Oxford Capital has been recognised multiple times as Best EIS Fund Manager. We have invested over £400m in small companies across the UK and are proud of partnering with some exceptional founders. Our current portfolio includes some well known brands such as Curve, Moneybox, Push Doctor, Spoke and more. More information can be found at www.oxcp.com.

Contact: Matthew Barnes

Contact: Becky Rees